Amphetamine Sulfate Tablet
FDA Label NDC 0406-1220

37 label sections · Submitted to the FDA by Specgx Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Specgx Llc for the product Amphetamine Sulfate (NDC 0406-1220). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, contraindications, abuse, misuse, and addiction, risks to patients with serious cardiac disease, increased blood pressure and heart rate, psychiatric adverse reactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.